SUMMARY Twenty five patients with peripheral neuropathy at different stages of human immunodeficiency virus (HIV) infection are reported. Cerebrospinal fluid (CSF) findings were available in 17 cases, electrophysiology in all and a neuromuscular biopsy in 11. Of six otherwise asymptomatic HIV + patients, five had chronic inflammatory demyelinating polyneuropathy (CIDP) and one acute inflammatory demyelinating polyneuropathy (AIDP). CSF showed pleocytosis in all cases. Infiltration of the endoneurium and/or the epineurium by mononuclear cells was seen in biopsies from three cases. These six patients recovered either spontaneously, or with corticosteroids or plasmaphereses. Of five patients with AIDS related complex (ARC), three had distal predominantly sensory peripheral neuropathy(DSPN), one CIDP and one mixed neuropathy. Of 14 patients with AIDS, one had mononeuropathy multiplex and 13 painful DSPN. Electrophysiological studies were consistent with an axonopathy. Nerve biopsies in six cases showed axonal changes but surprisingly associated with marked segmental demyelination in two cases. Cell infiltration was present in nerve samples in two cases. Five patients died within six months after the onset of the neuropathy.
Various disorders of the peripheral nervous system associated with HIV infection have been reported. In nine to 16% of patients with AIDS and 20% of patients with ARC'-3 their incidence has probably been underestimated. Some recent reviews have tried to classify peripheral neuropathies and other muscular complications."7 On the other hand, de la Monte et at did not distinguish between the neuropathy of AIDS and the neuropathy of ARC and suggested that these syndromes be regarded as the same disease process with variable expression. We report clinical, electrophysiological and pathological findings in 25 patients who manifested a peripheral neuropathy at different stages of HIV infection.
Methods
Information included the following: age, sex, risk factor for HIV infection, duration of HIV infection and characteristics of the peripheral neuropathy. Follow up studies were conducted over a period of one month to four years.
Laboratory investigations Serum specimens were analysed for the antibody to HIVI by enzyme-linked immunosorbent assay, and positive sera were confirmed by Western blots. Peripheral blood CD4/CD8 ratio was available in 20 cases. CSF cellularity, protein and glucose levels were obtained in 17 cases.
Electrodiagnostic studies included examination with concentric needle electrode and nerve conduction velocities in all cases. Motor nerve conduction velocities were determined on peroneal and median nerves by surface electrodes. Sensory nerve action potential amplitude and conduction velocities were determined on sural and median nerves by near-nerve needle electrodes. Criteria for demyelinating neuropathies Leger, Bouche, Bolgert, Chaunu, Rosenheim, Cathala, Gentilini, Hauw, Brunet 
The spectrum ofpolyneuropathies in patients infected with HIV segmental demyelination in two cases (23 and 24) . Cell infiltrates were found in cases 12 and 13 (where the duration of the HIV disease was one and seven months respectively) and absent in cases 14, 16, 23 and 24 (where the duration ofthe HIV disease was 16 months, two years, 10 months and 21 months respectively).
Discussion
Peripheral nervous system (PNS) manifestations of AIDS and ARC have become more and more widely recognised,7 12-t8 but there are relatively few papers on the clinical features and the natural history of peripheral neuropathy. Systematic electrophysiological studies have been conducted in HIV patients and have shown a high frequency of abnormalities.' 2' Nerve biopsies" 22 have shown either axonal or demyelinating changes, and frequent mononuclear cell infiltration in the early stages of the HIV infection.
Based on clinical and laboratory criteria, several distinct types of peripheral neuropathies have been identified but questions persist regarding the correlations with the HIV-infection stages and the electrophysiological and pathological findings. In our study, otherwise asymptomatic patients presented an inflammatory demyelinating polyneuropathy (IDP), mainly subacute. These findings were strikingly similar to those previously reported.'3 82324 Two features differentiate this type of neuropathy from common IDP: CSF pleocytosis, associated with high protein level, and inflammatory cell infiltrates in nerve biopsies. The predominant cell type has been found to be CD8 positive.'3 " IDP occurs at relatively early stages of the disease, before severe immunodeficiency, and probably results from immunopathogenic mechanisms (macrophage-mediated demyelination) rather than direct viral infection.'3 In three other published cases, IDP has been shown to be a symptom of HIV 2526au seroconversion. For other authors, the presence of cytomegalovirus (CMV) in the Schwann cells in previously published cases of Guillain-Barre syndrome associated with HIV infection,27 increases the likelihood that CMV may play a causative role in some patients. IDP usually improves spontaneously with corticosteroids or plasmaphereses7 '3 but response to treatment is not uniform and the absence of response may be a sign of poor prognosis.7 In our series, the long-term prognosis was good.
In ARC the spectrum of the peripheral neuropathy was heterogeneous, usually distal symmetrical axonopathies, but also mixed axonal-demyelinating polyneuropathy and chronic IDP. Prognosis seems to be worse than in otherwise asymptomatic patients. In our series most patients failed to progress satisfactorily and some of them developed AIDS. Four 
